IRIS - Res&Arch Institutional Research Information System - Research & Archive

SORCI, Guglielmo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.548
EU - Europa 5.609
AS - Asia 5.403
SA - Sud America 1.002
Continente sconosciuto - Info sul continente non disponibili 413
AF - Africa 135
OC - Oceania 15
Totale 20.125
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.324
SG - Singapore 2.361
IT - Italia 1.161
UA - Ucraina 898
BR - Brasile 792
HK - Hong Kong 775
CN - Cina 774
IE - Irlanda 733
RU - Federazione Russa 636
SE - Svezia 576
VN - Vietnam 432
DE - Germania 351
FR - Francia 288
KR - Corea 274
FI - Finlandia 235
GB - Regno Unito 209
IN - India 131
TR - Turchia 128
BD - Bangladesh 119
CA - Canada 97
NL - Olanda 96
RO - Romania 80
AT - Austria 76
IQ - Iraq 67
MX - Messico 60
AR - Argentina 59
PL - Polonia 59
JP - Giappone 48
CH - Svizzera 45
CO - Colombia 45
ZA - Sudafrica 43
PH - Filippine 38
PK - Pakistan 38
ES - Italia 36
EC - Ecuador 33
UZ - Uzbekistan 31
ID - Indonesia 30
BE - Belgio 28
VE - Venezuela 27
MA - Marocco 21
CZ - Repubblica Ceca 18
JM - Giamaica 18
SA - Arabia Saudita 18
MY - Malesia 17
LB - Libano 16
CL - Cile 14
JO - Giordania 12
LT - Lituania 12
PY - Paraguay 12
TN - Tunisia 12
CR - Costa Rica 11
EG - Egitto 11
EU - Europa 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
AZ - Azerbaigian 10
KE - Kenya 10
GR - Grecia 9
IR - Iran 9
MD - Moldavia 9
SK - Slovacchia (Repubblica Slovacca) 9
BG - Bulgaria 8
PE - Perù 8
DZ - Algeria 7
IL - Israele 7
ET - Etiopia 6
HN - Honduras 6
NI - Nicaragua 6
OM - Oman 6
TH - Thailandia 6
TW - Taiwan 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
KH - Cambogia 5
NP - Nepal 5
AL - Albania 4
GT - Guatemala 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
BY - Bielorussia 3
DK - Danimarca 3
GE - Georgia 3
KW - Kuwait 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
Totale 19.682
Salva come PNG Salva come JPEG
Città #
Singapore 1.776
Chandler 871
Hong Kong 758
Dublin 728
San Jose 630
Ashburn 515
Jacksonville 492
San Mateo 418
Perugia 305
Boardman 296
Santa Clara 290
Moscow 238
Seoul 202
Wilmington 188
Medford 187
Princeton 185
Lauterbourg 178
Beijing 166
Dong Ket 140
Los Angeles 130
Ann Arbor 129
The Dalles 121
Andover 114
New York 112
Ho Chi Minh City 108
Altamura 100
Munich 87
Piscataway 85
São Paulo 69
Izmir 68
Lawrence 68
Bucharest 64
Des Moines 61
Vienna 59
Hanoi 55
Saint Petersburg 55
Dearborn 53
Norwalk 53
Shanghai 53
Redmond 52
Helsinki 47
Orem 44
Phoenix 43
Falls Church 41
Montreal 40
Council Bluffs 39
Rome 37
Tokyo 37
Dallas 33
Philadelphia 33
Turin 33
Bologna 31
Warsaw 31
Rio de Janeiro 30
Shenzhen 29
Woodbridge 29
Milan 28
Brussels 27
Johannesburg 27
Atlanta 26
Boston 26
Houston 26
Chicago 25
Amsterdam 23
Brooklyn 23
Baghdad 22
Denver 22
Frankfurt am Main 22
London 22
Stockholm 22
Chennai 21
Falkenstein 21
Turku 21
Nuremberg 19
Seongnam-si 19
Buffalo 18
Brasília 17
Da Nang 17
Guangzhou 17
Toronto 17
Belo Horizonte 16
Manchester 16
San Francisco 16
Tashkent 16
Lahore 15
Redwood City 15
Dhaka 14
Florence 14
Ankara 13
Cebu City 13
Mexico City 13
Tijuana 13
Charlotte 12
Mumbai 12
Olomouc 12
Parma 12
Porto Alegre 12
Quito 12
Auburn Hills 11
Haiphong 11
Totale 11.632
Salva come PNG Salva come JPEG
Nome #
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 287
Le proteine S100 277
Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells 205
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 200
An HMGB1/RAGE/p38 MAPK/Myogenin Axis Modulates Pax7 Expression in Myoblasts by Both Transcriptional and Post-Transcriptional Mechanisms 185
Histological muscle characterization in hypertrophied Marchigiana cattle breed 179
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 178
Artesunate induces ROS-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells. 169
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 162
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 156
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 152
RAGE in the pathophysiology of skeletal muscle. 150
Extracellular S100B causes nuclear translocation of NF-?B in rat L6 myoblasts likely by binding to RAGE 148
Differential expression of S100B protein and RAGE in young and aged human satellite cells. 145
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 145
Equisetum arvense standardized extract hinders age-related sarcopenia 144
Biological effects of astrocyte-derived S100-beta protein on BV-2 microglial cell line 144
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 142
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 142
A braking circuit between pathogen- and danger-sensing signaling pathways restrains lung inflammation: role of S100B protein, RAGE and Toll-like receptors. 141
Amphoterin-induced myogenic differentiation of RAGE-transfected rhabdomyosarcoma TE671 cells 138
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 138
Cellular and molecular mechanisms of sarcopenia: the S100B perspective 138
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 138
Activation of RAGE in myoblasts and rhabdomyosarcoma cells results in downregulation of Pax7 expression 136
Effect of recombinant murine tumor necrosis factor on the generation of natural killer cells in bone marrow cultures 136
Natural products to counteract muscle atrophy 136
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 134
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 134
RAGE signalling in myoblasts and embryonal rhabdomyosarcoma cells represses Pax7 expression via p38 MAPK-dependent induction of myogenin. 132
An ultrastructural study of Sertoli cells inside alginate microcapsules. 132
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 131
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 130
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 130
The calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of the type III intermediate filaments 128
Amphoterin stimulates myogenesis and counteracts the anti-myogenic factors, bFGF and S100B, via RAGE binding 128
Aged vs young human satellite cells: altered expression of S100B and RAGE, and defective ability in conditioning the medium contribute to impaired myogenic potential. 128
"Neuron-specific" protein gene product 9.5 (PGP 9.5) is also expressed in glioma cell lines and its expression depends on cellular growth 126
S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond 125
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 125
RAGE expression in rhabdomyosarcoma cells results in reduced proliferation, migration, and invasiveness in vitro and tumor growth in vivo 122
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis 121
Histological Muscle Characterization in Hypertrophied Marchigiana Beef Cattle Breed 120
Implication of RAGE and Amphoterin in Myogenesis 119
Different intrinsic properties of young and aged human satellite cells. 118
Glial S100B protein in neuroprotection and neurodegeneration 116
Appropriate levels of extracellular S100B protein in injured muscle are required for correct muscle regeneration. 116
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 116
Association of S100B with intermediate filaments and microtubules in glial cells 113
The role of a mindful movement-based program (Movimento Biologico) in health promotion: results of a pre-post intervention study 111
S100B retards the biochemical differentiation of myoblasts and their fusion into myotubes 111
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 110
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 110
The effects of microgravity on human skeletal muscle regeneration. 110
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 110
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 109
Young and Aged Human Muscle Satellite Cells Show Differential Expression of S100B Protein and RAGE. 109
Role of calcium-binding proteins (S100B, annexin II2-p112, annexin VI) in the regulation of GFAP intermediate filament dynamics 109
RAGE signaling in myoblasts and rhabdomyosarcoma cells causes downregulation of Pax7 expression via p38 MAPK activation and upregulation of myogenin expression 108
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 108
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 108
S100B neuroprotective effect against ßamyloid-driven neurotoxicity 107
S100B inhibits myotube formation 107
S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner 107
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 107
Effects of S100B and S100A1 on cytoplasmic microtubules in triton-cytoskeletons from cell lines 106
Synergistic regulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation 106
RAGE engagement in myoblasts modulates proliferation, apoptosis, adhesiveness, migration and invasiveness 106
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 106
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 106
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 104
S100B protein in tissue development, repair and regeneration 104
The calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of type III intermediate filaments 103
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 103
Immunocytochemical detection of S100A1 and S100B in fused myotubes and related immunochemical analyses 103
Cellular growth state-dependent expression of annexin V in glioma cell lines. 103
Immunocytochemistry of S100B, annexin V and annexin VI in glial and microglial cells. 102
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation 102
Causes of elevated serum levels of S100B protein in athletes 102
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 102
Colocalization of S100B with intermediate filaments and microtubules in L6 myoblasts and U251 glial cells. 101
Caveolins and cavins in muscle-derived tumours. 100
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 100
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 100
Effects of extracellular S100B, a calcium-binding protein of the EF-hand type, on a skeletal muscle cell line 99
Complex regulatory effects of extracellular S100B on myoblast differentiation: S100B activates quiescent myoblats and satellite cells 99
Effects of deletion of RAGE in muscle regeneration: preliminary observations. 99
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 99
Is the binding of S100A1 (and S100B) to synapsin I physiologically relevant? 99
The calcium-modulated proteins, S100B and S100A1, disassemble cytoplasmic microtubules in situ. An in vitro study using triton-cytoskeletons from cell lines 98
S100B protein differentially regulates myoblast differentiation via direct binding to RAGE and bFGF-mediated activation of FGFR1 in low-density and high-density cultures, respectively 98
Functions of S100 proteins 98
Detection of membrane-bound guanylate cyclase activity in rat C6 glioma cells at different growth states following activation by natriuretic peptides 97
S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration 97
S100 proteins in obesity: liaisons dangereuses 97
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 97
Reductive stress in striated muscle cells 97
S100B and S100A1 disassemble cytoplasmic microtubules in triton-cytoskeletons from glioma and myoblast cells 96
S100B modulates beta-amyloid-induced neurotoxicity 95
Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. 95
Totale 12.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.355 0 0 42 123 61 24 31 496 22 56 202 298
2022/20232.622 218 375 43 219 228 288 7 137 970 10 91 36
2023/20241.242 62 98 53 51 53 32 319 41 149 40 153 191
2024/20253.476 69 323 236 152 480 139 275 307 556 173 561 205
2025/20266.682 438 383 291 927 850 631 1.139 348 711 529 321 114
2026/2027631 247 224 160 0 0 0 0 0 0 0 0 0
Totale 20.125